Clinical Development Hub
Local Demo
Home/regulatory/submissions

Submissions

Submission portfolio and dossier readiness management. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.

Submission Portfolio

Submissions
5,000
Validation Stage
1,084
Review Holds
219

Dossier Readiness Queue

1
SUBM-1200 | STUDY-0001
Submission | due 2026-01-01
2
SUBM-1201 | STUDY-0002
RFI | due 2026-02-02
3
SUBM-1202 | STUDY-0003
Substantial Modification | due 2026-03-03
4
SUBM-1203 | STUDY-0004
Validation | due 2026-04-04
5
SUBM-1204 | STUDY-0005
Results Prep | due 2026-05-05
6
SUBM-1205 | STUDY-0006
Submission | due 2026-06-06
7
SUBM-1206 | STUDY-0007
Validation | due 2026-07-07
8
SUBM-1207 | STUDY-0008
RFI | due 2026-08-08
9
SUBM-1208 | STUDY-0009
RFI | due 2026-09-09
10
SUBM-1209 | STUDY-0010
Substantial Modification | due 2026-10-10
Access & Governance Controls
RBAC+ABACStudy Firewall ActiveRestricted Zone

Operational Controls

Study firewalling chips highlight boundary, country constraints, and vendor partition rules.

Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.

Every state change writes immutable audit evidence with actor, timestamp, and object reference.

Next Actions

Filter to portfolio/program/study context.

Open linked tasks, risks, and document evidence.

Escalate blocked items through governed workflow.